Cargando…
MCM2 and NUSAP1 Are Potential Biomarkers for the Diagnosis and Prognosis of Pancreatic Cancer
Pancreatic cancer (PC) is one of the most malignant tumors. Despite considerable progress in the treatment of PC, the prognosis of patients with PC is poor. The aim of this study was to identify potential biomarkers for the diagnosis and prognosis of PC. First, the original data of three independent...
Autores principales: | Deng, Yajun, Ma, Hanyun, Hao, Jinyong, Xie, Qiqi, Zhao, Ruochen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7206867/ https://www.ncbi.nlm.nih.gov/pubmed/32420375 http://dx.doi.org/10.1155/2020/8604340 |
Ejemplares similares
-
Decreased Expression of NUSAP1 Predicts Poor Overall Survival in Cervical Cancer
por: Xie, Qiqi, et al.
Publicado: (2020) -
MCM2, MCM4, and MCM6 in Breast Cancer: Clinical Utility in Diagnosis and Prognosis()()
por: Issac, Marianne Samir Makboul, et al.
Publicado: (2019) -
Comprehensive pan-cancer analysis reveals NUSAP1 is a novel predictive biomarker for prognosis and immunotherapy response
por: Zheng, Hong, et al.
Publicado: (2023) -
Alternatively activated NUSAP1 promotes tumor growth and indicates poor prognosis in hepatocellular carcinoma
por: Shi, Chao, et al.
Publicado: (2019) -
NUSAP1 Could be a Potential Target for Preventing NAFLD Progression to Liver Cancer
por: Zeng, Taofei, et al.
Publicado: (2022)